![Andrea Pfeifer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrea Pfeifer
Oprichter bij AC IMMUNE SA
Vermogen: 10 M $ op 30-06-2024
Actieve functies van Andrea Pfeifer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AC IMMUNE SA | Directeur/Bestuurslid | 01-01-2016 | - |
Algemeen Directeur | 13-02-2003 | - | |
Oprichter | 13-02-2003 | - | |
Investor Relations Contact | 13-02-2003 | - | |
SYMRISE AG | Directeur/Bestuurslid | 01-05-2011 | - |
Independent Dir/Board Member | 01-05-2011 | - | |
University of Lausanne | Corporate Officer/Principal | - | - |
BioMedInvest AG I
![]() BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Voorzitter | - | - |
AB2 Bio SA
![]() AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Voorzitter | - | - |
Loopbaan van Andrea Pfeifer
Eerdere bekende functies van Andrea Pfeifer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
2INVEST AG | Directeur/Bestuurslid | 27-05-2010 | 18-10-2012 |
Nestlé Nespresso SA
![]() Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | 01-01-1998 | - |
Inventages II
![]() Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Oprichter | - | - |
BioMedPartners AG
![]() BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Voorzitter | 29-08-2002 | - |
░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van Andrea Pfeifer
Wuerzburg Schweinfurt University of Applied Sciences | Doctorate Degree |
Statistieken
Internationaal
Zwitserland | 8 |
Duitsland | 4 |
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Chairman | 3 |
Sectoraal
Finance | 5 |
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
AC IMMUNE SA | Health Technology |
2INVEST AG | Finance |
SYMRISE AG | Process Industries |
Bedrijven in privébezit | 6 |
---|---|
Nestlé USA, Inc.
![]() Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Nestle USA, Inc. produces dairy and bakery products. Its products include chocolate and confectionaries, beverages, ice cream, juices, milk products, pet food, prepared foods, and sports nutrition. The company is headquartered in Arlington, VA. | Process Industries |
BioMedPartners AG
![]() BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Finance |
BioMedInvest AG I
![]() BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Finance |
AB2 Bio SA
![]() AB2 Bio SA Pharmaceuticals: MajorHealth Technology AB2 Bio SA develops and manufactures drugs. The firm's products include Interleukin-18 Binding Protein and Proprietary Assay. The company was founded in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
Inventages II
![]() Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Finance |
Nestlé Nespresso SA
![]() Nestlé Nespresso SA Industrial MachineryProducer Manufacturing Nestlé Nespresso SA designs and manufactures espresso machines. The company was founded in 1986 and is headquartered in Zurich, Switzerland. | Producer Manufacturing |
- Beurs
- Insiders
- Andrea Pfeifer
- Ervaring